Sanofi expands PA vaccine facility to prepare for dengue launch

Sanofi ($SNY) plans to manufacture its highly anticipated dengue vaccine in a French facility built specifically for the product. But Sanofi Pasteur's vaccine operation in Swiftwater, PA, is also expanding in preparation for a launch of the vax, which may happen later this year. More from FiercePharmaManufacturing

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.